Egg-based Quadrivalent Influenza Vaccine
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £16K
- Sector
- HEALTH
- Published
- 05 Apr 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Movianto, Unit1, Haydock Green, PennyLane, Haydock, WA119DT
Geochart for 2 buyers and 1 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Aventis Pharma Guildford
Description
This procurement is for the supply of egg-based quadrivalent influenza vaccine to NHSScotland for use in the annual seasonal influenza immunisation programme.
Total Quantity or Scope
This procurement is for the supply of egg-based quadrivalent influenza vaccine for use in the annual seasonal influenza immunisation programme.
Award Detail
| 1 | Aventis Pharma (Guildford)
|
CPV Codes
- 33651660 - Influenza vaccines
Indicators
Legal Justification
The egg-based quadrivalent influenza vaccine is procured for the vaccination of infants aged 6 months to 2 years. Aventis Pharma t/a Sanofi is currently the only supplier of egg-based quadrivalent influenza vaccine that is licenced for use from age 6 months.
Other Information
The values referred to in sections II.1.7 and V.2.4 cover the full twelve (12) month duration of the contract. (SC Ref:686766)
Reference
- FTS 009067-2022